Pinealon
Also known as: EDR peptide, Glu-Asp-Arg, T-33, EDR tripeptide
Short regulatory tripeptide / peptide bioregulator (cytogen)
What it is
Pinealon is a short peptide studied in animal models for cognitive protection, hypoxia resistance, and anti-aging effects, particularly in the brain. It is thought to work by entering cell nuclei and influencing gene expression. No FDA-approved use; primarily studied in Russian research with limited independent replication.
The scientific side
Pinealon (Glu-Asp-Arg) is a synthetic tripeptide that has been shown to penetrate into animal cell nuclei, where it may interact with DNA and histone proteins, binding preferentially to CNG and CAG nucleotide sequences and influencing gene expression epigenetically. In the context of Alzheimer's disease pathogenesis, the EDR peptide is proposed to modulate the MAPK/ERK signaling pathway and influence synthesis of proapoptotic proteins (caspase-3, p53), antioxidant enzymes (SOD2, GPX1), and transcription factors including PPARA and PPARG. Pinealon restricts reactive oxygen species (ROS) accumulation in a dose-dependent manner in cerebellar granule cells, neutrophils, and PC12 cells, and modulates the cell cycle via delayed ERK 1/2 activation. It stimulates serotonin expression in aging brain cortex cultures, with molecular docking indicating complementarity to the CCTGCC nucleotide sequence in the tryptophan hydroxylase gene. In hypoxia models, pinealon promotes neurogenesis and reduces neuroinflammatory reactions, and stimulates antioxidative enzyme systems rather than directly scavenging ROS (PMID 25051764, PMID 18546825). Short peptides including pinealon can interact with the major groove of DNA, affecting guanine N7 and O6 atoms.
Class: Short regulatory tripeptide / peptide bioregulator (cytogen)
Administration & storage
- Administration
- Intraperitoneal injection (PMID: 21809624)
- Storage
- No storage conditions for pinealon are described in the reviewed abstracts.
- Cautions
- Prooxidant activity was detected by chemiluminescence in a human study of patients taking pinealon.,Pinealon increased caspase-3 activity moderately in false-operated (sham surgery) animals, suggesting possible context-dependent effects on apoptotic signaling.,In vitro data show that pinealon elevates the stationary level of intracellular reactive oxygen species while simultaneously decreasing cell death, indicating complex and not fully understood redox effects.,No clinical trial safety data are available; the reviewed literature lacks formal human pharmacokinetic, pharmacodynamic, or toxicology studies.,Sterile technique is essential for any injectable preparation; however, no injectable human protocols for pinealon were identified in the reviewed literature.
Legal & regulatory status
Not stated in reviewed literature — requires manual verification
Not stated in reviewed literature — requires manual verification
Not stated in reviewed literature — requires manual verification
What it's studied for
- Neuroprotection and cognitive function / anti-aging (geroprotection) Mixed
- Pinealon demonstrated dose-dependent restriction of ROS accumulation in cerebellar granule cells, neutrophils, and PC12 cells and decreased necrotic cell death; protective effect accompanied by delayed ERK 1/2 activation and cell cycle modification. PMID 21978084 Khavinson et al., Rejuvenation Research (2011)
- Administration of pinealon to pregnant rats with hyperhomocysteinemia significantly improved offspring cognitive function (spatial orientation and learning ability) and increased resistance of cerebellum neurons to oxidative stress. PMID 22567179 Arutjunyan et al., Int J Clin Exp Med (2012)
- Pinealon and Vesugen demonstrated significant anabolic effect, improved CNS activity, and slowed the rate of aging by biological age indicators in 32 patients aged 41–83 with polymorbidity and organic brain syndrome; prooxidant activity was also detected. Pinealon and Vesugen did not affect chromatin condensation. PMID 26390612 Meshchaninov et al., Advances in Gerontology (2015)
- Review describes pinealon as one of the short peptide neuroprotectives with described cellular and molecular mechanisms of neuroprotective activity applied clinically in elderly and old-age patients. PMID 24738258 Umnov et al., Advances in Gerontology (2013)
- Combined use of oligopeptides including pinealon (glutamyl-asparagin-arginine complex) showed the most pronounced positive impact on biological age indicators among 110 subjects across different age groups. PMID 28539017 Myakotnykh et al., Advances in Gerontology (2016)
- Use of pinealon (1 capsule containing 100 mcg, 2 times a day for two weeks) by workers of locomotive brigades improved biological age parameters and indicators of adaptive reactions. PMID 22708445 Nazimko et al., Advances in Gerontology (2012)
- Hypoxia protection / antihypoxic effects Animal studies only
- Pinealon had the most pronounced antihypoxic effect among tested short regulatory peptides in a model of hypobaric hypoxia; its neuroprotective mechanism involves stimulation of antioxidative enzyme systems and possibly limiting excitotoxic effects of NMDA, rather than direct ROS inhibition. PMID 18546825 Kozina, Advances in Gerontology (2008)
- Pinealon (Glu-Asp-Arg) in old rats under acute hypoxic hypoxia promoted increase of neurogenesis and decrease of neuroinflammatory reactions to reference level; Cortexin reduced programmed cell death but maintained elevated IL-6. PMID 25051764 Mendzheritsky et al., Advances in Gerontology (2014)
- Pinealon and Cortexin in 18-month-old rats under acute hypobaric hypoxia and mild hypothermia influenced behavior and neurochemical indices; both preparations increased adrenergic mediator and serotonin accumulation in brain cortex. PMID 28509493 Mendzheritsky et al., Advances in Gerontology (2015)
- Intraperitoneal introduction of pinealon before carotid artery occlusion in old rats promoted survival; behavioral and caspase-3 activity changes were observed. PMID 21809624 Mendzheritsky et al., Advances in Gerontology (2011)
- Learning and memory enhancement (animal models) Animal studies only
- Pinealon had a prevalent positive effect on learning in both young and old rats in the Morris maze compared to cortexin; regional changes in caspase-3 activity in cerebral cortex and brainstem were identified. PMID 28976148 Mendzheritsky et al., Advances in Gerontology (2013)
- Offspring of pinealon-treated pregnant rats showed improved spatial orientation and learning ability in the setting of prenatal hyperhomocysteinemia. PMID 22567179 Arutjunyan et al., Int J Clin Exp Med (2012)
- Serotonin expression stimulation in brain cortex Animal studies only
- Glu-Asp-Arg peptide stimulated serotonin expression in aging cultures of brain cortex cells and epigenetically regulated serotonin synthesis via binding to the tryptophan hydroxylase gene; molecular docking confirmed complementarity to CCTGCC nucleotide sequence. PMID 24909721 Khavinson et al., Bull Exp Biol Med (2014)
- Skin cell proliferation (in vitro) In vitro only
- Tripeptide T-33 (Glu-Asp-Arg) produced a stimulating effect on cell proliferation in skin explants from young rats; effect associated with reduced apoptosis as shown by p53 expression immunocytochemistry. PMID 22803085 Voicekhovskaya et al., Bull Exp Biol Med (2012)
- Occupational health / psychoemotional adaptation in professional drivers Human observational
- Combined application of pinealon and vezugen restored adaptive potential, improved psychoemotional indices, intensified resistance to work stress, and reduced occupational risk of borderline mental disorders in lorry-drivers (p < 0.001–0.05). PMID 23734521 Bashkireva & Artamonova, Advances in Gerontology (2012)
- Small peptides (cytogens) including pinealon restored and enhanced adaptive resources and corrected work ability index in people working with occupational hazards. PMID 28509489 Bashkireva & Kachan, Advances in Gerontology (2015)
- Pineal gland cell culture – signaling molecule expression (in vitro) In vitro only
- Glu-Asp-Arg (pinealon) did not affect expression of apoptosis marker AIF in organotypic pineal gland culture; other peptides (Ala-Glu-Asp-Gly and Lys-Glu-Asp) stimulated Ki-67 proliferative protein expression. PMID 22803060 Khavinson et al., Bull Exp Biol Med (2011)
- Antioxidant and membrane-stabilizing effects (in vitro) In vitro only
- Pinealon did not demonstrate direct antioxidant activity but restricted lipid peroxidation of human lipoproteins by modification of their structure; increased stability of red blood cell membranes toward osmotic hemolysis; elevated intracellular ROS stationary level while decreasing percent of dead cells in neuronal po PMID 18546826 Kozina et al., Advances in Gerontology (2008)
- Alzheimer's disease – potential therapeutic target (mechanistic/review) Mixed
- EDR (Glu-Asp-Arg) is proposed to enter cells, bind to histone proteins and/or RNA, modulate MAPK/ERK, reduce proapoptotic proteins (caspase-3, p53), increase antioxidant enzyme synthesis (SOD2, GPX1), and interfere with dendritic spine elimination in neuronal cultures from AD/Huntington's disease mice; normalizes behav PMID 33396470 Khavinson et al., Molecules (2020)
- Orthopaedic recovery / circadian and mitochondrial regulation (review claim) Animal studies only
- Review notes pinealon targets circadian and mitochondrial regulators as a recovery-enhancing agent in the orthopaedic context; preclinical studies noted as promising but clinical trials are currently lacking. PMID 41490200 Rahman et al., J Am Acad Orthop Surg Glob Res Rev (2026)
Safety signals
- Prooxidant activity detected by chemiluminescence in humans taking pinealon; noted alongside significant anabolic effect. PMID 26390612
- Decrease of CD34+ positive hematopoietic polypotent cells in blood, indicating significant inhibition of hemopoiesis, observed in study participants taking pinealon and vesugen. PMID 26390612
- Moderate increase in caspase-3 activity in false-operated (sham surgery) animal brains following pinealon administration, suggesting potential proapoptotic effect in non-ischemic brain. PMID 21809624
- Pinealon elevates stationary intracellular ROS levels in in vitro models while decreasing cell death — dual and potentially complex redox effects. PMID 18546826
Contraindications
- No specific contraindications for pinealon are stated in the reviewed abstracts. The study of geroprotective methods noted that dry carbon dioxide baths and hyperbaric oxygenation had contraindications, but pinealon and therapeutic massage were identified as the safest techniques in the comparative analysis. PMID 28539017
Protocol
No community protocol on record. In clinical studies, Pinealon was dosed at 100 µg (1 capsule) twice daily Oral (capsule) (PMID 22708445).
All studies (21)
- PMID 23734521 Human observational
Occupational health / psychoemotional adaptation in professional drivers - PMID 28509489 Human observational
Occupational health / psychoemotional adaptation in professional drivers - PMID 21978084 Mixed
Neuroprotection and cognitive function / anti-aging (geroprotection) - PMID 22567179 Mixed
Neuroprotection and cognitive function / anti-aging (geroprotection) - PMID 22708445 Mixed
Neuroprotection and cognitive function / anti-aging (geroprotection) - PMID 24738258 Mixed
Neuroprotection and cognitive function / anti-aging (geroprotection) - PMID 26390612 Mixed
Neuroprotection and cognitive function / anti-aging (geroprotection) - PMID 28539017 Mixed
Neuroprotection and cognitive function / anti-aging (geroprotection) - PMID 33396470 Mixed
Alzheimer's disease – potential therapeutic target (mechanistic/review) - PMID 18546825 Animal studies only
Hypoxia protection / antihypoxic effects - PMID 18546826 In vitro only
Antioxidant and membrane-stabilizing effects (in vitro) - PMID 21809624 Animal studies only
Hypoxia protection / antihypoxic effects - PMID 22117547
- PMID 22803060 In vitro only
Pineal gland cell culture – signaling molecule expression (in vitro) - PMID 22803085 In vitro only
Skin cell proliferation (in vitro) - PMID 24909721 Animal studies only
Serotonin expression stimulation in brain cortex - PMID 25051764 Animal studies only
Hypoxia protection / antihypoxic effects - PMID 28509493 Animal studies only
Hypoxia protection / antihypoxic effects - PMID 28976148 Animal studies only
Learning and memory enhancement (animal models) - PMID 30762356
- PMID 41490200 Animal studies only
Orthopaedic recovery / circadian and mitochondrial regulation (review claim)
Frequently asked
What is Pinealon and what is it made of?
Pinealon is a synthetic short regulatory tripeptide composed of glutamic acid, aspartic acid, and arginine (Glu-Asp-Arg), also referred to as the EDR peptide (PMID 21978084, PMID 33396470). It belongs to a class of short bioregulatory peptides called cytogens and has been studied for neuroprotective, antioxidant, and geroprotective effects.
How does Pinealon work?
Research suggests pinealon penetrates cell nuclei and may interact with DNA, binding preferentially to CNG and CAG nucleotide sequences and potentially influencing gene expression epigenetically. It has been shown to restrict ROS accumulation dose-dependently, reduce necrotic cell death, and modify the cell cycle via ERK 1/2 activation in preclinical models. It is also proposed to modulate the MAPK/ERK pathway and influence synthesis of antioxidant enzymes and transcription factors relevant to Alzheimer's disease pathogenesis. It stimulates serotonin synthesis in brain cortex cells by binding to the tryptophan hydroxylase gene.
What dose of Pinealon should I take?
I'm not a medical professional and can't recommend a protocol for you specifically. What research has shown: One human occupational health study reported a dose of 100 µg (1 capsule) taken twice daily for 2 weeks. Other human studies do not report specific doses numerically. Most mechanistic data come from animal or in vitro studies where exact dosing is not translatable to human use. Please consult a licensed healthcare provider.
Is Pinealon safe to use?
The reviewed literature reports some safety signals. A human study noted prooxidant activity by chemiluminescence and significant inhibition of hemopoiesis (decreased CD34+ cells) in participants taking pinealon. Animal data showed a moderate increase in caspase-3 activity in sham-surgery brain tissue following pinealon administration. In vitro studies show pinealon elevates intracellular ROS while reducing cell death — a complex and not fully understood effect. One review notes a current lack of clinical trials. Please consult a licensed healthcare provider before use.
Can Pinealon help with Alzheimer's disease?
I can't suggest treatments for medical conditions. Please speak with a licensed healthcare provider. What the reviewed research shows: The EDR (Glu-Asp-Arg) peptide has been studied in cell cultures from mice with Alzheimer's and Huntington's diseases, where it interfered with elimination of dendritic spines. It is proposed to modulate signaling pathways relevant to Alzheimer's pathogenesis. One review notes it improves memory issues in elderly patients, but formal clinical trial data are not described in the reviewed literature.
What is the difference between Pinealon and Epithalon (Epitalon)?
Both are short synthetic regulatory peptides studied in the context of aging and neuroprotection. Epithalon (Ala-Glu-Asp-Gly) is a tetrapeptide while Pinealon (Glu-Asp-Arg) is a tripeptide; both were found to penetrate into the cell nucleus in HeLa cells. In vitro, epithalon and pinealon both restricted lipid peroxidation and stabilized red blood cell membranes, though neither showed direct antioxidant activity; a key difference noted was that epitalon, unlike pinealon and other tested peptides, did not decrease the percent of dead cells in neuronal populations. For detailed comparisons, please consult the primary literature or a healthcare provider.
Can I stack Pinealon with Vesugen or other peptides?
I can't recommend combining compounds — that's a prescribing decision. Here's what has been studied individually: Multiple studies used pinealon in combination with vesugen (lysyl-glutamyl-asparagin complex) and reported improved psychoemotional indices and geroprotective effects in human studies (PMID 23734521, PMID 28539017). However, these are observational or clinical studies without formal dose-optimization or safety characterization of the combination. Please consult a licensed healthcare provider.
Where can I buy Pinealon?
I don't recommend vendors or sources. Please consult a licensed provider.
Has Pinealon been tested in clinical trials?
Formal randomized controlled clinical trials were not described in the reviewed abstracts. One review specifically noted that 'there is a current lack of clinical trials' for peptides in this class. Human studies in the reviewed literature were mostly small observational or non-randomized clinical studies in occupational health and geriatric settings (PMID 22708445, PMID 26390612, PMID 23734521). For the latest clinical trial status, please consult ClinicalTrials.gov or a licensed healthcare provider.
Does Pinealon help with learning and memory?
Preclinical animal studies have shown that pinealon has a positive effect on learning in both young and old rats in the Morris maze compared to cortexin, and offspring of pinealon-treated pregnant rats demonstrated improved spatial orientation and learning in a hyperhomocysteinemia model. One review mentions improved memory in elderly patients, but detailed clinical data are not provided in the reviewed abstracts. I can't make recommendations for individual use; please consult a licensed healthcare provider.